Is AI taking our jobs? What help is AI for doctors? There will be no scope for doctors if AI […]

In the world of medicine, timing can mean everything – especially in cancer detection.
Imagine a powerful tool that doesn’t just read mammograms, but sees the invisible risks, predicting who might develop breast cancer even before symptoms appear.
Every year, thousands of women receive normal mammogram results -only to be diagnosed with breast cancer months later.
These are known as interval breast cancers, and they tend to be more aggressive and harder to treat than cancers caught during routine screening.
Now, scientists from the University of Cambridge and the Radiological Society of North America (RSNA) have unveiled a powerful ally in the fight against these missed cases: artificial intelligence (AI).
Published in Radiology, their large-scale study demonstrates that an AI tool can accurately identify women at higher risk of developing interval breast cancers – allowing for earlier detection and potentially saving lives.
Led by Dr. Fiona J. Gilbert and Joshua W.D. Rothwell (M.B.B.S./Ph.D. student), the team used data from 134,217 women, aged 50–70 years, participating in the U.K. triennial Breast Screening Program.
Between 2014 and 2016, these women underwent digital mammography at two screening centers using different imaging systems.
Among them, 524 women later developed interval breast cancers– cancers that appeared between regular screening appointments.
To find out if AI could have predicted these cases, researchers applied Mirai, a deep learning-based algorithm designed for mammogram analysis.
The algorithm processed only negative mammograms (where no cancer was detected) and generated a risk score for each woman -estimating her likelihood of developing an interval cancer before the next screening.
Unlike traditional risk models that rely on family history or demographics, Mirai looks directly at the mammogram itself. It scans for complex image patterns, breast tissue density, and subtle pixel-level features that may indicate higher cancer susceptibility, even when the image appears normal to the human eye.
This AI-driven risk assessment represents a shift toward personalized screening, where imaging intervals and methods could be tailored based on each woman’s short-term cancer risk.
“We can use supplemental imaging and adjust screening frequency based on a woman’s breast density and likelihood of developing breast cancer within a short timeframe,” – Dr. Fiona J. Gilbert, University of Cambridge.
The study’s results highlight AI’s role in helping physicians:
Such AI-assisted approaches could be especially valuable for women with dense breast tissue, where cancers can be easily masked on standard mammograms.
Interval breast cancers develop between scheduled screenings – often within a year or two of a “normal” mammogram. They are typically:
By predicting who is most at risk, AI systems like Mirai could help prevent these cancers from going undetected until it’s too late.
This study marks a milestone in the integration of AI into preventive oncology. Rather than replacing radiologists, AI serves as a decision-support tool, enhancing their ability to interpret images and stratify patients by risk.
The findings also support a growing trend in precision medicine – tailoring healthcare not just to diseases, but to the individual biological profiles of patients.
Artificial intelligence is rewriting the rules of breast cancer screening. By using tools like Mirai, clinicians can spot hidden risks long before visible signs appear, enabling earlier detection and more personalized care.
This innovation could transform how we approach women’s health – moving from routine screening to predictive prevention.
AI doesn’t replace radiologists – it empowers them. Together, human expertise and algorithmic insight may help close the gap between detection and prevention.